Antisense modulation of gcgr expression

• 收藏
• 分享

专利权人:

IONIS PHAMACEUTICALS INC.

发明人:

FREIER SUSAN M.,BHANOT SANJAY

申请号：

NZ62239812

公开号：

NZ622398A

申请日:

2012.09.20

申请国别(地区):

NZ

年份:

2016

代理人:

摘要：

Disclosed is a compound comprising a modified oligonucleotide 12 to 30 linked nucleosides in length and having a nucleobase sequence comprising an at least 12 nucleobase portion of SEQ ID NO: 11 (GGTTCCCGAGGTGCCCA), and related use in the manufacture of a medicament for treatment a disease or condition associated with GCGR or an increase in blood glucose levels.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/